TITLE:
Cure for Alzheimer’s Disease
AUTHORS:
Nishant Patnaik
KEYWORDS:
Alzheimer’s Disease, Cure for Alzheimer’s Disease, Treatment Drugs, Acetylcholine, Inhibitors
JOURNAL NAME:
World Journal of Neuroscience,
Vol.5 No.5,
September
30,
2015
ABSTRACT: Alzheimer’s disease (AD)
is progressively being recognized amongst the most vital medical and social
issues in older individuals in industrialized and non-industrialized countries.
To date, just symptomatic medications exist for this disease, all attempting to
offset the neurotransmitter disturbance.Recently,
cholinesterase inhibitors (CIs) are now accessible and have been authorized for
the treatment of mild to moderate AD. Further remedial alternative available
for moderate to severe AD is memantine, an N-methyl-D-aspartate receptor
noncompetitive antagonist. Treatments equipped for halting or slightly
adjusting the course of AD are known as “ailment changing” medications, and are
still under extensive examination. To obstruct the movement of the ailment,
they need to interfere with the pathogenic steps in charge of the clinical
symptoms, including the disposition of extracellular amyloidβplaques and intracellular
neurofibrillary tangle formation, irritation, oxidative damage, iron
deregulation and cholesterol metabolism. This paper discusses the cure for
Alzheimer’s disease, the current symptomatic treatments and the treatment of
mild and moderate Alzheimer’s disease and the functions of its drugs.